Cevimeline Hydrochloride (Apotex Corp.)
Welcome to the PulseAid listing for the Cevimeline Hydrochloride drug offered from Apotex Corp.. This Cholinergic Muscarinic Agonists [MoA],Cholinergic Receptor Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Apotex Corp. |
NON-PROPRIETARY NAME: | cevimeline hydrochloride |
SUBSTANCE NAME: | CEVIMELINE HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Cholinergic Muscarinic Agonists [MoA],Cholinergic Receptor Agonist [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2012-10-08 |
END MARKETING DATE: | 0000-00-00 |
Cevimeline Hydrochloride HUMAN PRESCRIPTION DRUG Details:
Item Description | Cevimeline Hydrochloride from Apotex Corp. |
LABELER NAME: | Apotex Corp. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 30(mg/1) |
START MARKETING DATE: | 2012-10-08 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 60505-3145_1d0c0c59-07c0-bc3d-726d-d1513c6a3391 |
PRODUCT NDC: | 60505-3145 |
APPLICATION NUMBER: | ANDA091260 |
Other CEVIMELINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: